Para and Hepatic enzyme increased - a phase IV clinical study of FDA data

Summary:

Hepatic enzyme increased is reported as a side effect among people who take Para (para - aminobenzoic acid (paba)), especially for people who are female, 40-49 old, have been taking the drug for 1 - 2 years also take Prednisone, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Hepatic enzyme increased when taking Para. It is created by eHealthMe based on reports of 2,184 people who have side effects when taking Para from the FDA, and is updated regularly.

What is Para?

Para has active ingredients of para - aminobenzoic acid (paba). eHealthMe is studying from 2,194 Para users. Check the latest studies of Para.

What is Hepatic enzyme increased?

Hepatic enzyme increased is found to be associated with 1,885 drugs and 2,014 conditions by eHealthMe. Check the latest studies of Hepatic enzyme increased.

On Jul, 21, 2026

2,184 people reported to have side effects when taking Para.
Among them, 61 people (2.79%) have Hepatic enzyme increased.

Could Para cause Hepatic enzyme increased?

Among these 61 people:

How long have people been on Para when they have Hepatic enzyme increased? *

What is the gender of people who have Hepatic enzyme increased when taking Para? *

female: 97.96 %
male: 2.04 %

What is the age of people who have Hepatic enzyme increased when taking Para? *

What are other drugs people take besides Para? *

What are other side effects people have besides Hepatic enzyme increased? *

Infection: 46 people, 75.41%
Irritable Bowel Syndrome: 45 people, 73.77%
Infusion Related Reaction: 45 people, 73.77%
Joint Swelling: 43 people, 70.49%
Impaired Healing: 43 people, 70.49%
Helicobacter Infection (helicobacter pylori (h. pylori) infects stomach): 43 people, 70.49%
Duodenal Ulcer Perforation (untreated ulcer can burn through the wall of the stomach): 42 people, 68.85%
Hypersensitivity: 42 people, 68.85%
High Blood Pressure: 42 people, 68.85%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 42 people, 68.85%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 41 people, 67.21%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 33 people, 54.10%
Psoriasis (immune-mediated disease that affects the skin): 30 people, 49.18%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 20 people, 32.79%
Inflammation: 13 people, 21.31%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 12 people, 19.67%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 12 people, 19.67%
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder): 11 people, 18.03%
Pain: 11 people, 18.03%
Fever: 10 people, 16.39%

* Approximation only. Some reports may have incomplete information.

Do you take Para and have Hepatic enzyme increased?

- Check whether Hepatic enzyme increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Para:

Para (2,194 reports)

Hepatic enzyme increased treatments and more:

Hepatic enzyme increased (74,970 reports)

How severe was Hepatic enzyme increased and when was it recovered:

Hepatic enzyme increased in Para

Expand to all the drugs that have ingredients of para - aminobenzoic acid (paba):

Hepatic enzyme increased and drugs with ingredients of para - aminobenzoic acid (paba)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Para:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatic enzyme increased:

Hepatic enzyme increased (1,885 drugs)

Browse all the conditions that are associated with Hepatic enzyme increased:

Hepatic enzyme increased (2,014 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on para - aminobenzoic acid (paba) (the active ingredients of Para) and Para (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.